This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Rheumatology
In conversation with consultant rheumatologist Professor Paul Emery
Read more
Rheumatic diseases associated with reproductive issues and adverse pregnancy outcomes, study finds
Read more
Abatacept found to halt the progression of rheumatoid arthritis in high risk patients
Read more
MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis
Read more
Anti-IL17 peptide shows high clinical efficacy for immune-related inflammatory diseases
Read more
Do JAK inhibitors increase the risk of MACE in atopic eczema?
Read more
Psoriatic arthritis risk estimation tool reasonably accurate in psoriasis patients, study finds
Read more
The evolving management of psoriatic arthritis
Read more
EULAR develops points to consider for psoriasis to psoriatic arthritis transition
Read more
Apremilast benefits in psoriatic arthritis revealed by magnetic resonance imaging
Read more
Use of colchicine associated with reduced risk of hip and knee replacement
Read more
Long-term opioid use risk in one in three patients with rheumatic and MSK conditions
Read more
Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors
Read more
Two phase 3 trials find bimekizumab effective in both forms of axial spondyloarthritis
Read more
Osteoarthritis progression identifiable using plasma proteomics signature
Read more
Study investigates anti-rheumatic drug dose and incident retinopathy
Read more
Meet the Expert: Philip Mease on psoriatic arthritis
Read more
Page 1 of 9
1
2
3
4
5
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: